Charles River Laboratories (CRL)
288.50
-4.85 (1.65%)
Upcoming Events
Latest Headlines
Form 4 CHARLES RIVER LABORATORI For: Aug 25 Filed by: FOSTER JAMES C
August 27, 2026 4:22 PM - SEC Filing
Form 144 CHARLES RIVER LABORATORI Filed by: FOSTER JAMES C
August 25, 2026 4:11 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Aug 19 Filed by: Girshick Birgit
August 20, 2026 4:37 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Aug 19 Filed by: Parisotto Shannon M
August 20, 2026 4:34 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Aug 18 Filed by: Andrews Nancy C
August 20, 2026 4:31 PM - SEC Filing
Charles River and Medigen to use NGS for enterovirus vaccine work
August 20, 2026 8:03 AM - StreetInsider
Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing
August 20, 2026 8:00 AM - BizWire
Form 144 CHARLES RIVER LABORATORI Filed by: Parisotto Shannon M
August 19, 2026 4:16 PM - SEC Filing
Form 144 CHARLES RIVER LABORATORI Filed by: Andrews Nancy C
August 18, 2026 11:06 AM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Aug 11 Filed by: Girshick Birgit
August 13, 2026 4:38 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Aug 11 Filed by: Parisotto Shannon M
August 13, 2026 4:36 PM - SEC Filing
Form SCHEDULE 13G CHARLES RIVER LABORATORI Filed by: Invesco Ltd.
August 13, 2026 2:19 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Aug 10 Filed by: LaPlume Joseph W
August 11, 2026 4:39 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Aug 10 Filed by: FOSTER JAMES C
August 11, 2026 4:36 PM - SEC Filing
Form 144 CHARLES RIVER LABORATORI Filed by: Parisotto Shannon M
August 11, 2026 4:18 PM - SEC Filing
Form 144 CHARLES RIVER LABORATORI Filed by: Girshick Birgit
August 11, 2026 4:08 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Aug 06 Filed by: Knell Michael Gunnar
August 10, 2026 4:40 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Aug 06 Filed by: Creamer Victoria L
August 10, 2026 4:36 PM - SEC Filing
Form 144 CHARLES RIVER LABORATORI Filed by: FOSTER JAMES C
August 10, 2026 4:29 PM - SEC Filing
Charles River Labs (CRL) PT Raised to $300 at TD Cowen
August 10, 2026 7:42 AM - StreetInsider
Charles River Labs (CRL) PT Raised to $264 at Mizuho
August 10, 2026 7:12 AM - StreetInsider
Form 4 CHARLES RIVER LABORATORI For: Aug 05 Filed by: Parisotto Shannon M
August 6, 2026 4:49 PM - SEC Filing
Form 144 CHARLES RIVER LABORATORI Filed by: Creamer Victoria L
August 6, 2026 3:09 PM - SEC Filing
Form 144 CHARLES RIVER LABORATORI Filed by: Knell Michael Gunnar
August 6, 2026 3:09 PM - SEC Filing
Form SCHEDULE 13G/A CHARLES RIVER LABORATORI Filed by: FMR LLC
August 6, 2026 10:18 AM - SEC Filing
Charles River Labs (CRL) PT Raised to $291 at Baird
August 6, 2026 8:29 AM - StreetInsider
Charles River Labs (CRL) PT Raised to $305 at Jefferies
August 6, 2026 7:30 AM - StreetInsider
Charles River Labs (CRL) PT Raised to $282 at RBC Capital
August 6, 2026 6:44 AM - StreetInsider
JPMorgan Upgrades Charles River Labs (CRL) to Overweight
August 6, 2026 2:24 AM - StreetInsider
Form 144 CHARLES RIVER LABORATORI Filed by: Parisotto Shannon M
August 5, 2026 4:03 PM - SEC Filing
Charles River Labs (CRL) PT Raised to $300 at Evercore ISI
August 5, 2026 2:46 PM - StreetInsider
Form 10-Q CHARLES RIVER LABORATORI For: Jun 27
August 5, 2026 9:22 AM - SEC Filing
Charles River Laboratories (CRL) Tops Q2 EPS by 28c; Offers Guidance
August 5, 2026 7:43 AM - StreetInsider
Form 8-K CHARLES RIVER LABORATORI For: Aug 05
August 5, 2026 7:15 AM - SEC Filing
Charles River Laboratories Announces Second-Quarter 2026 Results
August 5, 2026 7:00 AM - BizWire
CLSA Downgrades Charles River Labs (CRL) to Hold (3)
July 20, 2026 3:26 AM - StreetInsider
Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call
July 15, 2026 8:00 AM - BizWire
Charles River to provide NGS services for Arovella cancer therapy
July 13, 2026 8:03 AM - StreetInsider
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
July 13, 2026 8:00 AM - BizWire
Charles River Labs (CRL) PT Raised to $255 at Baird
July 13, 2026 7:20 AM - StreetInsider
Charles River Labs (CRL) PT Raised to $230 at Mizuho
July 13, 2026 6:43 AM - StreetInsider
Charles River Labs (CRL) PT Raised to $260 at Morgan Stanley
July 9, 2026 8:15 AM - StreetInsider
Citi Adds Four Names to Catalyst Call List
July 8, 2026 5:18 AM - StreetInsider
Form 4 CHARLES RIVER LABORATORI For: Jun 29 Filed by: FOSTER JAMES C
July 1, 2026 4:59 PM - SEC Filing
William Blair Adjusts Monthly Analyst Conviction List for July 2026
July 1, 2026 6:19 AM - StreetInsider
Charles River Labs (CRL) PT Raised to $250 at Argus
July 1, 2026 3:56 AM - StreetInsider
Form 144 CHARLES RIVER LABORATORI Filed by: FOSTER JAMES C
June 29, 2026 4:45 PM - SEC Filing
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
June 18, 2026 8:00 AM - BizWire
Morgan Stanley favors Charles River Over IQVIA in CRO sector reset
June 17, 2026 8:47 AM - StreetInsider
Morgan Stanley Downgrades IQVIA Holdings (IQV) to Equalweight
June 17, 2026 6:29 AM - StreetInsider
Morgan Stanley Upgrades Charles River Labs (CRL) to Overweight, 'strong uptick in biopharma funding beginning to transition into RFPs and bookings'
June 17, 2026 6:29 AM - StreetInsider
Form 4 CHARLES RIVER LABORATORI For: Jun 05 Filed by: FOSTER JAMES C
June 8, 2026 4:26 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Jun 05 Filed by: Girshick Birgit
June 8, 2026 4:22 PM - SEC Filing
Form 4 CHARLES RIVER LABORATORI For: Jun 05 Filed by: Parisotto Shannon M
June 8, 2026 4:19 PM - SEC Filing
Full Article List
